![super health club visual novel vimeo super health club visual novel vimeo](https://66.media.tumblr.com/52fbec93dd9e3d5ab6daa6cf72ba5b7d/tumblr_nx8c50z6tv1usbyqwo1_500.jpg)
“Currently, the ability to write long and complex DNA is a critical bottleneck in the broader life sciences industry. “To achieve this goal, we will be rapidly expanding our interdisciplinary team to build our synthesizers, scale up production of our reagents, and launch our service.” We’re excited to have the support of our top-tier investor syndicate led by Northpond Ventures, and we look forward to bringing our enzymatically synthesized DNA to the market,” said Daniel Lin-Arlow, Ph.D., CEO & Co-founder of Ansa Biotechnologies. “Enzymatic DNA synthesis is rapidly becoming a commercial reality, and I believe we have the most advanced technology in terms of speed, length, and accuracy. The technology also has the potential to unlock new areas of life sciences research that have yet to be explored. These long molecules streamline the construction of even longer sequences and greatly facilitate the construction of “complex” sequences that power emerging synthetic biology applications but are difficult for current vendors to produce.Īnsa’s enzyme-based approach will dramatically accelerate innovation across almost every industry enabled by synthetic DNA– from biologic therapeutics such as antibodies, gene therapies, and cell therapies, to the biomanufacturing of chemicals, materials, foods, and biofuels, and even to futuristic applications such as DNA-based data storage. Since Ansa’s method uses exquisitely precise enzymes instead of harsh chemicals for all steps of the synthesis process, it does not damage the growing DNA as it is made, enabling the direct synthesis of sequences that are hundreds or possibly even thousands of bases long. Ansa’s novel enzymatic synthesis technology harnesses the power of nature’s machinery to synthesize DNA in an entirely new way that is substantially faster and more accurate than the chemical method. Currently, DNA is synthesized via a chemical method that has remained mostly unchanged for 40 years and uses harsh conditions that damage the growing molecules, limiting the length and accuracy of the DNA that is produced. To support this development, Ansa will expand its state-of-the-art R&D and manufacturing facilities and will grow its multidisciplinary team across biochemistry, chemistry, engineering, bioinformatics, and operations.Īnsa is on a mission to streamline the writing of DNA to power the next era of DNA-enabled industries.
![super health club visual novel vimeo super health club visual novel vimeo](http://comprarmarihuanamadrid.es/wp-content/uploads/2021/01/Diseno-sin-titulo-2021-01-25T160736.973.jpg)
The funding will be used to accelerate the development of Ansa’s next-generation enzymatic DNA synthesis technology based on polymerase-nucleotide conjugates, build high-throughput synthesizers, and launch its DNA synthesis service. The company has raised a total of $82 million from private financings to date.
SUPER HEALTH CLUB VISUAL NOVEL VIMEO SERIES
Ansa is solving current industry bottlenecks associated with synthesizing complex DNA sequences that are difficult to obtain from existing DNA synthesis providers.ĮMERYVILLE, Calif.–( BUSINESS WIRE)– Ansa Biotechnologies today announced it has closed an oversubscribed Series A financing round of $68 million led by Northpond Ventures, with participation from new investors RA Capital, Blue Water Life Science Advisors, Altitude Life Science Ventures, Fiscus Ventures, PEAK6 Strategic Capital, Carbon Silicon Ventures, Codon Capital, and existing investors Mubadala Capital, Humboldt Fund, Fifty Years, and Horizons Ventures.
![super health club visual novel vimeo super health club visual novel vimeo](https://www.ryuugames.com/wp-content/uploads/2020/10/will_0202pl-696x948.jpg)
Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service.Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage.